Webster Bank, N. A. »

Black Diamond Therapeutics shares owned by Webster Bank, N. A.

Quarter-by-quarter ownership of Black Diamond Therapeutics (BDTX) shares owned by Webster Bank, N. A. from 13F filings

Historical chart of Webster Bank, N. A. investment in Black Diamond Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Black Diamond Therapeutics held by Webster Bank, N. A. consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Black Diamond Therapeutics by Webster Bank, N. A.

Quarter filed Position value Share count Share price at filing
2025-09-30 $23k 6.0k 3.79

More positions owned by Webster Bank, N. A.

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
JPMorgan Chase & Co. (JPM)
Amazon (AMZN)
Vanguard Malvern Fds Strm Infproidx (VTIP)
Wisdomtree Tr Floatng Rat Trea (USFR)
Wal-Mart Stores (WMT)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Tr Core Us Aggbd Et (AGG)
Ishares Tr Intrm Gov Cr Etf (GVI)

View all positions for Webster Bank, N. A.

Top funds holding Black Diamond Therapeutics

T. Rowe Price Investment Management
Vestal Point Capital
NEA Management Company
Vanguard Group
Tang Capital Management
Marshall Wace
Siren
BlackRock
Arrowstreet Capital, Limited Partnership
Millennium Management
UBS Group
AWM Investment Company
Renaissance Technologies
Geode Capital Management
Northern Trust

View all funds holding Black Diamond Therapeutics